337 related articles for article (PubMed ID: 33645231)
1. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme.
Checa-Chavarria E; Rivero-Buceta E; Sanchez Martos MA; Martinez Navarrete G; Soto-Sánchez C; Botella P; Fernández E
Mol Pharm; 2021 Apr; 18(4):1558-1572. PubMed ID: 33645231
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells.
Valdez L; Cheng B; Gonzalez D; Rodriguez R; Campano P; Tsin A; Fang X
Oncotarget; 2022; 13():642-658. PubMed ID: 35548329
[TBL] [Abstract][Full Text] [Related]
3. Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model.
Schiapparelli P; Zhang P; Lara-Velazquez M; Guerrero-Cazares H; Lin R; Su H; Chakroun RW; Tusa M; Quiñones-Hinojosa A; Cui H
J Control Release; 2020 Mar; 319():311-321. PubMed ID: 31911154
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
[TBL] [Abstract][Full Text] [Related]
5. Antitumor compound testing in glioblastoma organotypic brain cultures.
Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
8. Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines.
Morandi E; Severini C; Quercioli D; D'Ario G; Perdichizzi S; Capri M; Farruggia G; Mascolo MG; Horn W; Vaccari M; Serra R; Colacci A; Silingardi P
Mol Cancer; 2008 Aug; 7():66. PubMed ID: 18694480
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
10. OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
Berenguer-Daizé C; Astorgues-Xerri L; Odore E; Cayol M; Cvitkovic E; Noel K; Bekradda M; MacKenzie S; Rezai K; Lokiec F; Riveiro ME; Ouafik L
Int J Cancer; 2016 Nov; 139(9):2047-55. PubMed ID: 27388964
[TBL] [Abstract][Full Text] [Related]
11. Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis.
Lin CJ; Lin YL; Luh F; Yen Y; Chen RM
Oncotarget; 2016 Jul; 7(27):42408-42421. PubMed ID: 27285755
[TBL] [Abstract][Full Text] [Related]
12. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
13. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
[TBL] [Abstract][Full Text] [Related]
14. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma.
Yang N; Yan T; Zhu H; Liang X; Leiss L; Sakariassen PØ; Skaftnesmo KO; Huang B; Costea DE; Enger PØ; Li X; Wang J
J Transl Med; 2014 Oct; 12():278. PubMed ID: 25280402
[TBL] [Abstract][Full Text] [Related]
15. Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme.
Bona NP; Pedra NS; Azambuja JH; Soares MSP; Spohr L; Gelsleichter NE; de M Meine B; Sekine FG; Mendonça LT; de Oliveira FH; Braganhol E; Spanevello RM; da Silveira EF; Stefanello FM
Metab Brain Dis; 2020 Feb; 35(2):283-293. PubMed ID: 31773434
[TBL] [Abstract][Full Text] [Related]
16. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells.
Jalili-Nik M; Abbasinezhad-Moud F; Sahab-Negah S; Maghrouni A; Etezad Razavi M; Khaleghi Ghadiri M; Stummer W; Gorji A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070493
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.
Bensalma S; Chadeneau C; Legigan T; Renoux B; Gaillard A; de Boisvilliers M; Pinet-Charvet C; Papot S; Muller JM
J Mol Neurosci; 2015 Jan; 55(1):51-61. PubMed ID: 25280457
[TBL] [Abstract][Full Text] [Related]
19. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
